2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow KW-2478: new trials by email Literature Review of KW-2478 trials Research Report on KW-2478
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma KW-2478, Bortezomib - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 95 | 2010-03-01 | 2024-04-25 |
| A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma KW-2478 - Multiple Myeloma, Chronic Lymphocytic Leukaemia | Phase 1 | Completed | Kyowa Kirin Co., Ltd. | 27 | 2007-04-01 | 2024-04-25 |
Bronchiolitis Obliterans Syndrome (2) · Hematologic Diseases (2) · Leukemia (2) · Leukemia, B-Cell (2) · Multiple Myeloma (2) · Blood Protein Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Monoclonal Gammopathy of Undetermined Significance (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1)
United Kingdom (2) · Philippines (1) · United States (1)
J D Cavenagh, MD. MRCP, MRCPath (1) · Loan Hoang-Sayag, MD (1) · Michael Kurman, MD (1) · Noel Pingoy, MD (1)
2009 (1)